These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23537982)

  • 1. Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study.
    Bagai A; Cantor WJ; Tan M; Tong W; Lamy A; Fitchett D; Cohen EA; Mehta SR; Borgundvaag B; Ducas J; Heffernan M; Džavík V; Morrison L; Schwartz B; Lazzam C; Langer A; Goodman SG
    Am Heart J; 2013 Apr; 165(4):630-637.e2. PubMed ID: 23537982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
    Cantor WJ; Fitchett D; Borgundvaag B; Heffernan M; Cohen EA; Morrison LJ; Ducas J; Langer A; Mehta S; Lazzam C; Schwartz B; Dzavik V; Goodman SG
    Am Heart J; 2008 Jan; 155(1):19-25. PubMed ID: 18082484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE).
    Czarnecki A; Welsh RC; Yan RT; DeYoung JP; Gallo R; Rose B; Grondin FR; Kornder JM; Wong GC; Fox KA; Gore JM; Goodman SG; Yan AT; ;
    Can J Cardiol; 2012; 28(1):40-7. PubMed ID: 22129488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial.
    Russo JJ; Goodman SG; Cantor WJ; Fitchett D; Heffernan M; Borgundvaag B; Ducas J; Cohen EA; Džavik V; Mehta SR; Buller CE; Yan AT;
    Heart; 2014 Jun; 100(11):873-80. PubMed ID: 24449716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-Results of the Swedish Early Decision reperfusion Study (SWEDES) trial.
    Aasa M; Henriksson M; Dellborg M; Grip L; Herlitz J; Levin LA; Svensson L; Janzon M
    Am Heart J; 2010 Aug; 160(2):322-8. PubMed ID: 20691839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
    Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
    J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI; McKay RG; Boden WE; Mather JF; White CM
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis: insights from the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
    Yan AT; Yan RT; Cantor WJ; Borgundvaag B; Cohen EA; Fitchett DH; Dzavik V; Ducas J; Tan M; Casanova A; Goodman SG;
    Eur Heart J; 2011 Aug; 32(16):1994-2002. PubMed ID: 21307037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction).
    Tan NS; Goodman SG; Cantor WJ; Tan MK; Yan RT; Bagnall AJ; Mehta SR; Fitchett D; Strauss BH; Yan AT;
    Am J Cardiol; 2014 Oct; 114(7):955-61. PubMed ID: 25118119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study.
    Vlaar PJ; Svilaas T; van der Horst IC; Diercks GF; Fokkema ML; de Smet BJ; van den Heuvel AF; Anthonio RL; Jessurun GA; Tan ES; Suurmeijer AJ; Zijlstra F
    Lancet; 2008 Jun; 371(9628):1915-20. PubMed ID: 18539223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: a subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
    Bhan V; Cantor WJ; Yan RT; Mehta SR; Morrison LJ; Heffernan M; Fitchett D; Džavík V; Ducas J; Borgundvaag B; Cohen EA; Goodman SG; Yan AT
    Am Heart J; 2012 Sep; 164(3):343-50. PubMed ID: 22980300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
    Dangas G; Aymong ED; Mehran R; Tcheng JE; Grines CL; Cox DA; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Lansky AJ; Stone GW;
    Am J Cardiol; 2004 Oct; 94(8):983-8. PubMed ID: 15476608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of early versus delayed invasive approach after fibrinolysis in acute myocardial infarction.
    Clever YP; Cremers B; Link A; Böhm M; Scheller B
    Circ Cardiovasc Interv; 2011 Aug; 4(4):342-8. PubMed ID: 21712524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of an early invasive strategy after fibrinolysis in ST-elevation myocardial infarction relative to the extent of coronary artery disease.
    Elbarouni B; Cantor WJ; Ducas J; Borgundvaag B; Džavík V; Heffernan M; Buller CE; Langer A; Goodman SG; Yan AT;
    Can J Cardiol; 2014 Dec; 30(12):1555-61. PubMed ID: 25475460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis.
    D'Souza SP; Mamas MA; Fraser DG; Fath-Ordoubadi F
    Eur Heart J; 2011 Apr; 32(8):972-82. PubMed ID: 21036776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
    Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Kochman W; Korecki J; Poniatowski B; Zuk J; Sitniewska E; Bachorzewska-Gajewska H; Sienkiewicz J; Musial WJ
    Eur Heart J; 2007 Oct; 28(20):2438-48. PubMed ID: 17884846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
    Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ;
    Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction.
    Thiele H; Engelmann L; Elsner K; Kappl MJ; Storch WH; Rahimi K; Hartmann A; Pfeiffer D; Kneissl GD; Schneider D; Möller T; Heberling HJ; Weise I; Schuler G;
    Eur Heart J; 2005 Oct; 26(19):1956-63. PubMed ID: 16061501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.